Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cullinan Therapeutics (CGEM) Depreciation & Amortization (CF) (2020 - 2023)

Cullinan Therapeutics has reported Depreciation & Amortization (CF) over the past 4 years, most recently at $77000.0 for Q4 2023.

  • Quarterly results put Depreciation & Amortization (CF) at $77000.0 for Q4 2023, up 30.51% from a year ago — trailing twelve months through Dec 2023 was $310000.0 (up 233.33% YoY), and the annual figure for FY2025 was $311000.0, up 1.63%.
  • Depreciation & Amortization (CF) for Q4 2023 was $77000.0 at Cullinan Therapeutics, down from $80000.0 in the prior quarter.
  • Over the last five years, Depreciation & Amortization (CF) for CGEM hit a ceiling of $81000.0 in Q2 2023 and a floor of $9000.0 in Q3 2022.
  • Median Depreciation & Amortization (CF) over the past 4 years was $15000.0 (2020), compared with a mean of $32375.0.
  • Biggest five-year swings in Depreciation & Amortization (CF): crashed 30.77% in 2022 and later soared 788.89% in 2023.
  • Cullinan Therapeutics' Depreciation & Amortization (CF) stood at $15000.0 in 2020, then decreased by 20.0% to $12000.0 in 2021, then surged by 391.67% to $59000.0 in 2022, then skyrocketed by 30.51% to $77000.0 in 2023.
  • The last three reported values for Depreciation & Amortization (CF) were $77000.0 (Q4 2023), $80000.0 (Q3 2023), and $81000.0 (Q2 2023) per Business Quant data.